SOLID CANCER
Clinical trials for SOLID CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCER trials appear
Sign up with your email to follow new studies for SOLID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a mushroom extract revive cancer Survivors' immune defenses?
Disease control Recruiting nowThis study tests whether PRaG-1, a cordycepin supplement, can increase CD8+ immune cells in people with solid tumors who have been cancer-free for at least six months after radiation or chemotherapy. About 127 participants will take the supplement for two weeks, and those who res…
Matched conditions: SOLID CANCER
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New hope for tough ovarian cancer: targeted drug R-DXd enters Late-Stage trial
Disease control Recruiting nowThis study tests a new drug called R-DXd for people with ovarian, peritoneal, or fallopian tube cancer that has stopped responding to platinum chemotherapy. The drug is designed to target and kill cancer cells while sparing healthy ones. About 860 participants will be enrolled to…
Matched conditions: SOLID CANCER
Phase: PHASE2, PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New hope for advanced cancer: AK138D1 enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug called AK138D1 in up to 200 people with advanced solid tumors that haven't responded to standard treatments. The main goals are to check the drug's safety and find the best dose. Researchers will also look for signs that the drug can shrink…
Matched conditions: SOLID CANCER
Phase: PHASE1 • Sponsor: Akeso • Aim: Disease control
Last updated May 19, 2026 11:49 UTC
-
New cell therapy trial targets Hard-to-Treat solid tumors
Disease control Recruiting nowThis early-phase trial is testing a new treatment called TC-G203 for people with advanced solid tumors that have a specific marker (GPC3) and have not responded to standard therapies. The main goal is to find the safest dose and check for side effects. About 30 adults will take p…
Matched conditions: SOLID CANCER
Phase: EARLY_PHASE1 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Could a supplement boost cancer immunotherapy? new study investigates urolithin a.
Knowledge-focused Recruiting nowThis study tests whether a natural compound called urolithin A can improve the immune response in people with solid tumors (like lung cancer or melanoma) who are starting standard immunotherapy. About 45 adults will be randomly assigned to take either urolithin A or a placebo alo…
Matched conditions: SOLID CANCER
Phase: NA • Sponsor: Goethe University • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC